The rising prices of existing and new brand prescription drugs could have serious consequences for tax payers and the 44 million seniors who rely on Medicare. In order to rein in those costs, it’s vital for the Administration to encourage the use of generic drugs and biosimilars. While Congress has been grabbing the headlines by…
Continue reading ›Articles Posted in PBM
While there is much discussion about controlling prescription drug prices, the undeniable trend in the generic drug industry is that prices have been trending down for the past several years. Generic Prices are Down, But Is that a Good Thing? The short term effects appear good for the consumer, but the longer term effects could…
Continue reading ›